Monique McHenry, PhD
Monique McHenry, PhD is a botanist with a background in plant diversity and evolution. She is the co-director of the cannabis pharmacology course at the University of Vermont Medical School. She is also Co-Founder of the Phytoscience Institute, a plant-based pharmaceutical research center. Dr. McHenry completed her BA and MSc at the University of Colorado, and her PhD at the University of Vermont.
Kalev Freeman, MD, PhD
Kalev Freeman, MD, PhD is a physician-scientist with a background in molecular biology and specific research interest in inflammation and injury. He is co-founder of the Phytoscience Institute and the Medical Director of Vermont Patients Alliance Inc., a non-profit, plant-based pharmaceutical research center that serves over 600 patients with debilitating medical conditions. He completed his BA at the University of Michigan, and both his MD and PhD at the University of Colorado, where he specialized in molecular biology.
Karen Lounsbury, PhD
Karen Lounsbury, PhD is a professor of pharmacology at the University of Vermont College of Medicine. Research in Dr. Lounsbury’s laboratory is focused on understanding mechanisms whereby signals generated at the plasma membrane are communicated to the nucleus of vascular cells to mediate vascular remodeling and angiogenesis. Signaling pathways of current interest include protein kinase cascades, hypoxia signaling and mechanisms of calcium-regulated gene transcription in arterial smooth muscle cells and ovarian tumor cells.
Willy Cats-Baril, PhD
Willy Cats-Baril, PhD is an associate professor for Information and Decision Sciences at the Grossman School of Business at the University of Vermont. Dr. Cats-Baril expertise is quality assurance and continuous improvement, assessment of medical outcomes, and certification and maintenance of competence programs. He is also an entrepreneur.
Wolfgang Dostmann, PhD
Wolfgang Dostmann, PhD is a professor of pharmacology at the University of Vermont College of Medicine, and teaches a course on cannabis pharmacology. His research interests focus on the topic of second messenger signaling, and he and his team specialize in research on the contraction function of muscle cells in blood vessels. Dr. Dostmann’s research is stimulated by and integrated through the use of a large variety of methods and techniques ranging from organic chemistry, biochemistry, molecular biology, cell biology, biophysics, physiology and pharmacology.
Frances Carr, PhD
University of Vermont
Professor, Department of Pharmacology
John MacKay, PhD
Senior Director, Strategic Technologies
John McPartland, DO, MS
University of Vermont College of Medicine, Family Medicine Department